Hypothyroidism, with its accompanying hypercholesterolaemia and hypertension has been found to be associated with cardiovascular disease. Moreover subclinical hypothyroidism is a strong indicator of risk for atherosclerosis and myocardial infarction. [7] [8] [9] [10] [11] [12] Hypothyroidism may also protect the heart muscle by reducing its workload and oxygen consumption. 5 Aging is associated with increased prevalence of thyroid function abnormalities including hypothyroidism. 13, 14 An increased prevalence of overt hypothyroidism (OH) and subclinical hypothyroidism (SH) has been consistently reported with frequency ranges from 0.5% to 5% for OH and 5% to 20% for SH in women older than 60-65 years. 13, 15 Many similarities between signs and symptoms of hypothyroidism and the aging process can be observed, such as bradycardia, hypertension, hypercholesterolaemia, weight gain, cold intolerance, constipation, muscle weakness, lethargy, cognitive dysfunction, depression, impotence and dry skin. 15 An age dependent decline of the thyroid function has been documented in the oldest old population. 1 A meta-analysis of 15 studies showed an increased prevalence and incidence of cardiovascular mortality only in a relatively younger population. Cardiovascular as well as all-cause mortality was also increased in studies involving subjects younger than 65 years. 16 At a younger age, hypothyroidism may synergize (through dyslipi-daemia, endothelial dysfunction or direct effect on the heart) with other genetic or environmental factors to increase the risk of IHD. In contrast, older subjects represent population with longer survival and lower cardiovascular risk, who might rather benefit from the energy sparing effects of mild hypothyroidism. 14 From these literatures it can be assumed that discrepancy in thyroid function status may exist in IHD patients of different age groups. However, such issue has not yet been properly addressed in our IHD patients. For this reason we designed this crosssectional comparative study to compare the thyroid function status in IHD patients of different age groups.
Materials and Methods
This cross sectional study was carried out in the Department of Physiology, Dhaka Medical College, Dhaka from July 2009 to June 2010. Total 100 subjects aged 35 to 85 years of both sexes were included in this study. Out of this 100, 50 apparently healthy subjects were controls (Group A) and 50 diagnosed and documented IHD patients were the cases (Group B). Group A was further divided into Group A 1 and Group A 2 on the basis of age. Subjects of 35-59 years were included in Group A 1 and subjects of 60-85 years were included in Group A 2 . Similarly Group B was also divided into Group B 1 (35-59 years) and Group B 2 (60-85 years).
The IHD subjects were selected from coronary care unit of cardiology department and OPD of Dhaka Medical College Hospital, Dhaka and control subjects were selected from Dhaka city by personal communication. Subjects with history of thyroid disease, chest pain for other causes or pregnancy were excluded. Ethical consideration for the subjects was taken into account before inclusion into the study. The aims and benefits of the study were explained to each subject and informed consent was taken. A detailed history regarding medical, personal, family and socio-economic condition was recorded in a preformed questionnaire. With all aseptic preparations 5 mL of venous blood was drawn and serum was separated. Serum FT 3 , FT 4 and TSH of all subjects were measured by radioimmunoassay in the laboratory for Nuclear Medicine and Ultrasound, Bangladesh Atomic Energy Commission, Dhaka Medical College Campus, Dhaka. Statistical analysis was done by unpaired Student's 't' test using SPSS version 12. Data were expressed as mean ± SD.
Results
Thirty six male and 14 female IHD patients and 34 male and 16 female healthy subjects participated in this study. Among healthy subjects 24 were in Group A 1 and 26 were in Group A 2 . Among IHD patients 31 were in Group B 1 and 19 were in Group B 2 .
The comparison of anthropometric parameter and thyroid hormone status between Group A 1 and Group B 1 are shown in Table I . The Group A 1 and Group B 1 were matched in terms of age and BMI (p>0.05). Although the mean serum FT 3 , FT 4 and TSH levels of both Group A 1 and Group B 1 were within normal reference value, but mean serum FT 3 and FT 4 were significantly lower and TSH level was significantly higher in Group B 1 than that of Group A 1 (p<0.05). 
Discussion
In the present study we intended to evaluate the influence of age on the thyroid hormone status in IHD patients. The mean ± SD of FT 3 and FT 4 were significantly lower and the mean ± SD of TSH was significantly higher in Group B 1 than that of Group A 1 (p<0.05). However, Group B 2 did not show such difference with the Group A 2 (p>0.05). No significant difference in any general characteristics and thyroid hormone status was observed between Group B 1 and Group B 2 (p>0.05). Several studies agree with the present findings. [14] [15] [16] [17] [18] [19] [20] Some investigators reported that mild hypothyroidism is associated with a significant increase of IHD risk only in middle aged (<65 yrs old) subjects, whereas mild thyroid failure may be harmless or beneficial in advanced age. 14, 17 It has been suggested that at a y ounger age hypothyroidism may synergize (through dyslipidaemia, endothelial dysfunction or direct effect on the heart) with other genetic or environmental factors to increase the risk of IHD. On the other hand older subjects represent population with longer survival and lower cardiovascular risk, who might rather benefit from the energy sparing effects of mild hypothyroidism. 14 Razvi et al explained the effect of age on vascular risk in subjects with hypothyroidism. First, it is possible that at a younger age, lack of thyroid hormones has a profound pathophysiological effect, resulting in accelerated vascular disease, perhaps through dyslipidaemia, endothelial dysfunction, or a direct effect on the myocardium in a proportion of susceptible individuals. As age of the subjects increases, they become relatively resistant to the adverse vascular effects of low thyroid activity. 16 C l inical manifestations of subclinical hypothy-roidism include abnormal lipid metabolism, cardiac dysfunction, elevated risk of atherosclerosis and coronary heart disease. 19 Overt hypothyroidism, with its accompanying hypercholesterolaemia and hypertension, has been found to be associated with cardiovascular disease. Subclinical hypothyroidism is strongly and independently associated with aortic atherosclerosis and myocardial infarction. 10 Reduced serum T 3 is a strong predictor of all-cause and cardiovascular mortality and, in fact, is a stronger predictor than age, left ventricular ejection fraction, or dyslipidaemia. 18 A meta-analysis found that mild hypothyroidism is associated with a significant increase of IHD risk only in middle-aged (<65 yrs old) subjects. This finding supports the concept that mild thyroid failure is detrimental in young to middle-aged subjects, whereas may be harmless or perhaps beneficial at advanced age. 14 However, data on the associations with coronary heart disease (CHD) events and mortality are conflicting among several large prospective cohorts. 11 Elderly normal population may have low thyroid hormone status. Some researchers reported that thyroid abnormality is more common in older age group than middle age group. 7, 21, 22 The prevalence of subclinical hypothyroidism approaches about 15% in women who are over 60 years of age. 19 It was also reported by Mariotti and Cambuli that the oldest subjects with lower cardiovascular risk might be benefited from the energy sparing effects of mild thyroid failure. The physiological function of thyroid hormone is to increase the O 2 consumption of all cells of the body. Mild thyroid failure in turn decreases O 2 consumption of the cells and thus reduces the cardiac workload. This is the possible mechanism by which mild thyroid failure plays a cardioprotective role in old age. An increased prevalence of overt hypothyroidism has been consistently reported with frequencies ranging from 0.5% to 5% for OH and from 5% to 20% for SH in women older than 60-65 years. 15 From the findings of the present study it can be concluded that thyroid hormone levels are significantly lower in younger IHD population compared with age-matched normal controls. There is no significant difference between the elderly IHD patients and age-matched normal controls and between younger IHD population and elderly IHD population regarding thyroid hormone status.
